Patients News | pharmaphorum

News

GSK et al file appeal to Delaware Zantac order

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead.

News

UK pharma industry delivers election ‘wish list’

The Association of the British Pharmaceutical Industry (ABPI) is calling on political parties contesting the general election to spell out their plans to nurture and drive growth in t

News

ALZpath licenses Alzheimer’s diagnosis tech to Roche

Diagnostics giant Roche is putting its weight behind a biomarker for Alzheimer’s disease developed by ALZpath.

News

Lilly’s Alzheimer’s drug set to join Leqembi after FDA vote

An FDA advisory committee has delivered a strong endorsement to Eli Lilly’s Alzheimer’s disease therapy donanemab, voting unanimously that the safety and efficacy of the amyloid-busti

News

Scotland first UK nation to clear Mounjaro use for obesity

Scotland has become the first country in the UK to back NHS use of Eli Lilly’s obesity therapy Mounjaro, clearing it to assist weight management in eligible patients.

News

Urgent plea for type O blood after London cyberattack

An appeal has been launched for blood donors across England to come forward in the wake of the cyberattack which has disrupted hospitals and GP practices in London, now th

GSK et al file appeal to Delaware Zantac order

UK pharma industry delivers election ‘wish list’

ALZpath licenses Alzheimer’s diagnosis tech to Roche

Lilly’s Alzheimer’s drug set to join Leqembi after FDA vote

Scotland first UK nation to clear Mounjaro use for obesity

Urgent plea for type O blood after London cyberattack

23andMe study explains variable results with obesity drugs

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks